Through the use of gene editing and gene modulation technologies, Horizon provides a wide range of products and services to customers across the life sciences based on the development of cell-based models and their application. Horizon’s powerful gene editing platform develops genetically engineered cell models which are used to understand the role of genomics in disease, the development of drug discovery assays and screening, to the production of biotherapeutics and other diagnostic tools.